For patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of the New England Journal of Medicine.
Oct 27, 2023
0
0
The U.S. Food and Drug Administration has approved UCB' Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis.
Oct 25, 2023
0
0
New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents will facilitate comparisons ...
Oct 20, 2023
0
1
Follow-on findings from an initial study showed that nursing home staff working after Ireland's pandemic restrictions had been lifted reported substantially higher levels of post-traumatic stress, moral injury, low mood and ...
Oct 16, 2023
0
20
Ciara Burns spent 42 days rowing across the Atlantic in 2021 as part of a team of 12. Clearly, whoever ventures on such an adventure has to go to the extreme limits both physically and mentally. Therefore, a situation like ...
Oct 10, 2023
0
1
Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder, according to a study published in Nature Medicine in September. Removing the ...
Oct 2, 2023
0
4
Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented from ...
Sep 11, 2023
0
19
The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the Sept. 7 issue of the New England Journal ...
Sep 8, 2023
0
26
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.
Assistant Professor Yuya Hosoda of the Center for IT-Based Education (CITE), Toyohashi University of Technology has developed a method for estimating the pitch of vocal cord vibrations of humans from call audio.
Aug 18, 2023
0
1
